Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Year: 2008
Type: article
Study design: Clinical Trial
Institutions: Duke University, Duke Medical Center, West Virginia University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2164965267
